You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

APOA2

Showing 1 - 25 of 264
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glycation of apoA-I and Diabetic Atherogenesis

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • overnight fasting
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Dec 11, 2022

Inflammation Trial in Boston (Animal Diet, Plant Diet)

Active, not recruiting
  • Inflammation
  • Animal Diet
  • Plant Diet
  • Boston, Massachusetts
    Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts
Apr 15, 2021

Liver Failure Trial in Antalya

Completed
  • Liver Failure
    • Antalya, Turkey
      AkdenizU
    Jul 13, 2023

    Hyperlipidemia Trial in Beijing (JS401, Placebo)

    Recruiting
    • Hyperlipidemia
    • Beijing, Beijing, China
      Peking University Third Hospital
    Sep 15, 2023

    Dyslipidemia, Atherosclerosis, Acute Coronary Syndrome Trial in Dallas (RVX000222, Placebo)

    Completed
    • Dyslipidemia
    • +3 more
    • Dallas, Texas
      Covance Clinical Research Unit, Inc.
    Nov 1, 2022

    COVID-19 Respiratory Infection, FLU, Cold; Influenza Trial in Kayseri (Kunamin®, Favipiravir, Enoxaparin)

    Completed
    • COVID-19 Respiratory Infection
    • +4 more
    • Kunamin®
    • +6 more
    • Kayseri, Kayseri Province, Turkey
      Kayseri City Hospital
    Jun 10, 2022

    Cardiovascular Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Fx-5A peptide complex)

    Recruiting
    • Cardiovascular Disease
    • Fx-5A peptide complex
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 7, 2022

    Nonalcoholic Steatohepatitis, Genetic Risk Factor Trial (ALN-PNP Dose Level 1, ALN-PNP Dose Level 2, ALN-PNP Dose Level 3)

    Not yet recruiting
    • Nonalcoholic Steatohepatitis
    • Genetic Risk Factor
    • ALN-PNP Dose Level 1
    • +3 more
    • (no location specified)
    Sep 5, 2023

    Hyperlipidemia Trial in Beijing (AK102, Placebo)

    Recruiting
    • Hyperlipidemia
    • AK102
    • Placebo
    • Beijing, China
      Peking University First Hospital
    Feb 15, 2022

    Familial Chylomicronemia Syndrome Trial in Canada, Sweden, United States (Olezarsen)

    Recruiting
    • Familial Chylomicronemia Syndrome
    • Huntington Beach, California
    • +10 more
    Aug 4, 2022

    Hyperlipemia Trial (SHR-1918, SHR-1918 )

    Not yet recruiting
    • Hyperlipemia
    • (no location specified)
    Jun 24, 2022

    Dyslipidemias, Overweight and Obesity Trial in Guadalajara (NUTRIGENETIC DIET INTERVENTION, CONVENTIONAL DIET INTERVENTION)

    Completed
    • Dyslipidemias
    • Overweight and Obesity
    • NUTRIGENETIC DIET INTERVENTION
    • CONVENTIONAL DIET INTERVENTION
    • Guadalajara, Jalisco, Mexico
      Institute of Translational Nutrigenetics and Nutrigenomics, Depa
    Jan 13, 2022

    Cholesterol, HDL, Lipid Metabolism, Inborn Errors, Tangier Disease Trial in Philadelphia (3H-cholesterol bound to albumin)

    Suspended
    • Cholesterol, HDL
    • +4 more
    • 3H-cholesterol bound to albumin
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jul 14, 2022

    Elevated Triglycerides Trial in London, Toronto (GFA-918, Placebo)

    Completed
    • Elevated Triglycerides
    • GFA-918
    • Placebo
    • London, Ontario, Canada
    • +1 more
    Dec 21, 2021

    Healthy Volunteers Trial in Medellín (Whole egg, Annatto-enriched egg, Egg whites - Control)

    Completed
    • Healthy Volunteers
    • Whole egg
    • +2 more
    • Medellín, Antioquia, Colombia
      Sede de Investigación Universitaria - Universidad de Antioquia
    Oct 21, 2021

    Hypercholesterolemia Trial in Clermont-ferrand, Clermont-Ferrand, Durtol (LIMICOL, PLACEBO)

    Completed
    • Hypercholesterolemia
    • LIMICOL
    • PLACEBO
    • Clermont-ferrand, France
    • +3 more
    Feb 28, 2023

    Cancer Related Fatigue Trial in Stavanger (REBECCA-assisted intervention)

    Recruiting
    • Cancer Related Fatigue
    • REBECCA-assisted intervention
    • Stavanger, Rogaland, Norway
      Stavanger University Hospital
    Nov 6, 2023

    Hypertriglyceridemia, Cardiovascular Diseases, Atherosclerosis Trial in United States (Olezarsen, Placebo)

    Recruiting
    • Hypertriglyceridemia
    • +2 more
    • Birmingham, Alabama
    • +17 more
    Jan 26, 2023

    Dyslipidaemia Trial in Denmark, Slovakia, United States (AZD8233, Placebo)

    Completed
    Has Results
    • Dyslipidaemia
    • Roseville, California
    • +18 more
    Nov 7, 2022

    Axial Spondyloarthritis Trial in Halmstad (High intensity interval training (HIIT), Control group)

    Recruiting
    • Axial Spondyloarthritis
    • High intensity interval training (HIIT)
    • Control group
    • Halmstad, Halland, Sweden
      Halmstad University
    Mar 12, 2023

    Epigenomic and Metabolomic Signatures of APOA2 Gene by Saturated

    Completed
    • Body Mass Index
    • None, cohort studies
    • Boston, Massachusetts
      JM-USDA-HNRCA at Tufts University
    Mar 1, 2018

    Aging, Cardiovascular Diseases, Overweight or Obesity Trial in Graz (Juice Plus+ Fruit, Vegetable and Berry blends, Juice Plus+

    Recruiting
    • Aging
    • +2 more
    • Juice Plus+ Fruit, Vegetable and Berry blends
    • Juice Plus+ Omega blend
    • Graz, Austria
    • +1 more
    Aug 3, 2022

    Coronary Artery Disease, Coronary Atherosclerosis, Nicotine Dependence Trial in Warsaw (heated tobacco - lifestyle intervention)

    Not yet recruiting
    • Coronary Artery Disease
    • +2 more
    • heated tobacco - lifestyle intervention
    • Warsaw, Poland
      National Institute of Cardiology
    Dec 27, 2022

    Hypertriglyceridemia, Atherosclerotic Cardiovascular Disease, Severe Hypertriglyceridemia Trial in Canada, United States

    Active, not recruiting
    • Hypertriglyceridemia
    • +2 more
    • Lincoln, California
    • +23 more
    Nov 23, 2022

    RNF213 Variants and Collateral Vessels in Moyamoya Disease

    Completed
    • Moyamoya Disease
    • Identification of genetic variants
    • Beijing, Beijing, China
      Beijing Tiantan Hospital Capital Medical University
    Feb 16, 2022